Jeroen J. Bax

Cardiology and Cardiovascular Medicine · 2004–2021

A researcher in the Science corpus: 43 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Jeroen J. Bax trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. G. Heusch (in Cardiology and Cardiovascular Medicine)

Papers from Jeroen J. Bax's perspective

Ordered by how strongly the researchers Jeroen J. Bax trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the ARIC Study (Circulation)
  2. In-stent restenosis in the drug-eluting stent era. (Journal of the American College of Cardiology)
  3. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of… (European Heart Journal-Cardiovascular Imaging)
  4. Exercise interventions on health-related quality of life for people with cancer during active treatment. (Cochrane Database of Systematic Reviews)
  5. Cardiac resynchronization in chronic heart failure. (New England Journal of Medicine)
  6. Recommendations for chamber quantification. (European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology)
  7. Cardiac-resynchronization therapy for mild-to-moderate heart failure. (New England Journal of Medicine)
  8. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. (Journal of the American College of Cardiology)
  9. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. (European Heart Journal-Cardiovascular Imaging)
  10. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. (The Lancet)

Their papers